Contractor
ADVANCED ACCELERATOR APPLICATIONS USA INC
- UEI
- JNM4NBNHFE66
- Parent UEI
- YE3YG1FDWMC5
- Resolved by
- uei
- Confidence
- 1.000
Active from Oct 1, 2022 to Oct 8, 2026.
Sign in to watchRecent awards
| Award | Agency | Place | First action | Current value |
|---|---|---|---|---|
| 36C25023F0063 18 DOSES OF PLUVICTO | Department of Veterans Affairs | NJ | Oct 1, 2022 | $194,774 |
| 36C24927N0149 VISN PADIOPHARMACEUTICAL PLUVICTO DRUG | Department of Veterans Affairs | NJ | Oct 1, 2026 | $960,239 |
| 36C26125F0023 PLUVICTO? (LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN) | Department of Veterans Affairs | NJ | Oct 1, 2024 | $1,063,332 |
| 36C24926N0263 VISN PADIOPHARMACEUTICAL PLUVICTO DRUG | Department of Veterans Affairs | NJ | Dec 16, 2025 | $5,075,550 |
| 36C25024F0021 DECREASING FUNDS NO LONGER NEEDED PLUVICTO (LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN) | Department of Veterans Affairs | NJ | Jul 8, 2026 | $422,010 |
| 36C25225F0020 PLUVICTO RADIOPHARM | Department of Veterans Affairs | IL | Jun 26, 2026 | $1,095,121 |
| 36C25523A0004 PLUVICTO AND LUTATHERA | Department of Veterans Affairs | — | Apr 6, 2023 | — |
| 36C26124N0090 DEOBLIGATE AND CLOSEOUT FY24 FUNDS, PO# 640C49015, FLUVICTO - LUTETIUM | Department of Veterans Affairs | NJ | May 1, 2026 | $1,819,183 |
| 36C25023F0658 LUTATHERA (LUTETIUM LU 177 DOTATATE) 3 DOSES DECREASE FOR CLOSE OUT | Department of Veterans Affairs | NY | Apr 21, 2026 | $39,260 |
| 36C26225F0145 VA PHOENIX PLUVICTO | Department of Veterans Affairs | NJ | Apr 16, 2026 | $664,583 |
| 36C26125F0002 DE-OB FY25 AND CLOSE OUT. PLUVICTO PROSTATE CANCER THERAPY VANCHCS - CLIN 0002 QUANTITY DECREASE. | Department of Veterans Affairs | NJ | Apr 9, 2026 | $1,693,772 |
| 75N90020P00063 TO ADMINISTRATIVELY DE-OBLIGATE UNEXPENDED AND EXPIRING FISCAL YEAR 2021 FUNDING IN ACCORDANCE WITH 31 U.S.C. SECTION 1552 (A), IN PREPARATION FOR SEPTEMBER 30, 2026, CLOSING OF THE PERIOD OF AVAILABILITY OF THESE FISCAL YEAR FUNDS. | Department of Health and Human Services | NJ | Apr 7, 2026 | $154,000 |
| 75N90020P00135 ADVANCED ACCELERATOR APPLICATIONS USA, INC.:1308250 [20-002108] | Department of Health and Human Services | NJ | Apr 7, 2026 | $171,500 |
| 36C26025N0127 RADIOPHARMACEUTICALS: LUTETIUM LU 177 PLUVICTO 27MCI/ML. | Department of Veterans Affairs | NJ | Apr 3, 2026 | $232,604 |
| 36C26225F0024 PLUVICTO AND LUTATHERA FY 25 REDUCE FUNDING AND CLOSE OUT | Department of Veterans Affairs | NJ | Mar 23, 2026 | $3,485,014 |
| 36C25525N0176 PLUVICTO AND LUTATHERA | Department of Veterans Affairs | KS | Feb 17, 2025 | $1,362,395 |
| 36C25526N0132 PLUVICTO AND LUTATHERA | Department of Veterans Affairs | KS | Jan 13, 2026 | $1,200,000 |
| 36C25524N0136 PLUVICTO AND LUTATHERA | Department of Veterans Affairs | NY | Jan 31, 2024 | $1,140,422 |
| 36C25523N0153 PLUVICTO AND LUTATHERA | Department of Veterans Affairs | NY | Apr 6, 2023 | $779,095 |
| HT941023F0088 5 PLUVICTO (LUTETIUM-177) | Department of Defense | NY | May 11, 2023 | $162,312 |
Sources and method
Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.
Totals sum obligations across every award attributed to this contractor. Obligations are cumulative funding actions, not the value of work delivered.
- 1Awards are attributed by Unique Entity Identifier JNM4NBNHFE66, the government's own recipient identifier, not by name matching.
- 2Award records from USAspending.gov, last refreshed Oct 21, 2026.